mRNA-1273.815
- Generic Name
- mRNA-1273.815
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 14246
- Registration Number
- NCT05815498
- Locations
- 🇺🇸
Mountain View Ogden Clinic/CCT Research, Pleasant View, Utah, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
🇺🇸J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
- Conditions
- SARS-CoV-2
- Interventions
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 1860
- Registration Number
- NCT05436834
- Locations
- 🇦🇷
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Ciudad Autónoma De BuenosAires, Argentina
🇦🇷AES - AS - Glenny Corp. S.A. Buenos Aires, Caba, Ciudad Autónoma De Buenos Aires, Argentina
🇦🇷AES - AS - Clinica Mayo de Urgencias, San Miguel de Tucumán, Tucumán, Argentina
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
- Conditions
- SARS-CoV-2
- Interventions
- First Posted Date
- 2021-06-15
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 5161
- Registration Number
- NCT04927065
- Locations
- 🇺🇸
Research Centers of America, Hollywood, Florida, United States
🇺🇸Jacksonville Center For Clinical Research, Jacksonville, Florida, United States
🇺🇸Meridian Clinical Research (Iowa), Sioux City, Iowa, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.